Growth inhibition and induction of apoptosis in SGC-7901 human gastric cancer cells by evodiamine

Molecular Medicine Reports

Volumn 9, Issue 4, 2014, Pages 1147-1152

  Yang, L I ^a   Liu, Xin ^a   Wu, Dan ^a   Zhang, Man ^a   Ran, Guiping ^a   Bi, Ying ^a   Huang, Hai ^a  

^a GUIZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Apoptosis; Cell cycle; Evodiamine; Growth inhibition; SGC 7901 cells

Indexed keywords

CASPASE 3; CASPASE 8; CASPASE 9; EVODIAMINE; PROTEIN BAX; PROTEIN BCL 2;

APOPTOSIS; ARTICLE; CANCER CELL; CANCER INHIBITION; CELL PROLIFERATION; CONTROLLED STUDY; DRUG EFFECT; DRUG INHIBITION; ENZYME ACTIVATION; ENZYME ACTIVITY; FLOW CYTOMETRY; G2 PHASE CELL CYCLE CHECKPOINT; HUMAN; HUMAN CELL; PROTEIN EXPRESSION; STOMACH CANCER;

APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; BLOTTING, WESTERN; CASPASES; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SHAPE; HUMANS; QUINAZOLINES; STOMACH NEOPLASMS;

EID: 84896531867     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2014.1924     Document Type: Article

References (19)

1. Jiang J and Hu C: Evodiamine: a novel anti-cancer alkaloid from Evodia rutaecarpa. Molecules 14: 1852-1859, 2009.
2. Lee TJ, Kim EJ, Kim S, Jung EM, Park JW, Jeong SH, Park SE, Yoo YH and Kwon TK: Caspase-dependent and caspase-independent apoptosis induced by evodiamine in human leukemic U937 cells. Mol Cancer Ther 5: 2398-2407, 2006. (Pubitemid 44530477)
3. Zhang Y, Wu LJ, Tashiro S, Onodera S and Ikejima T: Intracellular regulation of evodiamine-induced A375-S2 cell death. Biol Pharm Bull 26: 1543-1547, 2003. (Pubitemid 41699632)
4. Wang C, Wang MW, Tashiro S, Onodera S and Ikejima T: Roles of SIRT1 and phosphoinositide 3-OH kinase/protein kinase C pathways in evodiamine-induced human melanoma A375-S2 cell death. J Pharmacol Sci 97: 494-500, 2005. (Pubitemid 40628526)
5. Zhang Y, Wu LJ, Tashiro S, Onodera S and Ikejima T: Evodiamine induces tumor cell death through different pathways: apoptosis and necrosis. Acta Pharmacol Sin 25: 83-89, 2004. (Pubitemid 38076083)
6. Chen MC, Yu CH, Wang SW, Pu HF, Kan SF, Lin LC, Chi CW, Ho LL, Lee CH and Wang PS: Anti-proliferative effects of evodiamine on human thyroid cancer cell line ARO. J Cell Biochem 110: 1495-1503, 2010.
7. Kan SF, Huang WJ, Lin LC and Wang PS: Inhibitory effects of evodiamine on the growth of human prostate cancer cell line LNCaP. Int J Cancer 110: 641-651, 2004. (Pubitemid 38746021)
8. Kan SF, Yu CH, Pu HF, Hsu JM, Chen MJ and Wang PS: Anti-proliferative effects of evodiamine on human prostate cancer cell lines DU145 and PC3. J Cell Biochem 101: 44-56, 2007. (Pubitemid 46652571)
9. Huang DM, Guh JH, Huang YT, Chueh SC, Chiang PC and Teng CM: Induction of mitotic arrest and apoptosis in human prostate cancer pc-3 cells by evodiamine. J Urol 173: 256-261, 2005.
10. Liao CH, Pan SL, Guh JH, Chang YL, Pai HC, Lin CH and Teng CM: Antitumor mechanism of evodiamine, a constituent from Chinese herb Evodiae fructus, in human multiple-drug resistant breast cancer NCI/ADR-RES cells in vitro and in vivo. Carcinogenesis 26: 968-975, 2005. (Pubitemid 41214326)
11. Wang XN, Han X, Xu LN, Yin LH, Xu YW, Qi Y and Peng JY: Enhancement of apoptosis of human hepatocellular carcinoma SMMC-7721 cells through synergy of berberine and evodiamine. Phytomedicine 15: 1062-1068, 2008.
12. Zhu LH, Liu XD, Tan YH, Li JF, Du BY and Wu YY: Proliferation-inhibited and apoptosis-inducted effects of evodiamine on human hepatoma cell line HepG2. Chinese Pharmacological Bulletin 1: 68-71, 2009.
13. Fei XF, Wang BX, Li TJ, Tashiro S, Minami M, Xing DJ and Ikejima T: Evodiamine, a constituent of Evodiae Fructus, induces anti-proliferating effects in tumor cells. Cancer Sci 94: 92-98, 2003. (Pubitemid 36575865)
14. Ogasawara M, Matsubara T and Suzuki H: Inhibitory effects of evodiamine on in vitro invasion and experimental lung metastasis of murine colon cancer cells. Biol Pharm Bull 24: 917-920, 2001. (Pubitemid 32750318)
15. Ogasawara M and Suzuki H: Inhibition by evodiamine of hepa tocyte growth factor-induced invasion and migration of tumor cells. Biol Pharm Bull 27: 578-582, 2004 (Pubitemid 41701850)
16. Wei WT, Chen H, Wang ZH, Ni ZL, Liu HB, Tong HF, Guo HC, Liu DL and Lin SZ: Enhanced antitumor efficacy of gemcitabine by evodiamine on pancreatic cancer via regulating PI3K/Akt pathway. Int J Biol Sci 8: 1-14, 2012.
17. Chen W, Zheng R, Zhang S, et al: The incidences and mortalities of major cancers in China, 2009. Chin J Cancer 32: 106-112, 2013.
18. Huang H, Zhang Y, Liu X, Li Z, Xu W, He S, Huang Y and Zhang H: Acid sphingomyelinase contributes to evodiamine-induced apoptosis in human gastric cancer SGC-7901 cells. DNA Cell Biol 30: 407-412, 2011.
19. Gross A, McDonnell JM and Korsmeyer SJ: BCL-2 family members and the mitochondria in apoptosis. Genes Dev 13: 1899-1911, 1999. (Pubitemid 29407357)